192 related articles for article (PubMed ID: 12375682)
1. Extreme second-trimester serum analyte values in down syndrome pregnancies with hydrops fetalis.
Benn PA; Egan JF; Ingardia CJ
J Matern Fetal Neonatal Med; 2002 Apr; 11(4):262-5. PubMed ID: 12375682
[TBL] [Abstract][Full Text] [Related]
2. Correlation of ultrasound findings and biochemical markers in the second trimester of pregnancy in fetuses with trisomy 21.
Souter VL; Nyberg DA; El-Bastawissi A; Zebelman A; Luthhardt F; Luthy DA
Prenat Diagn; 2002 Mar; 22(3):175-82. PubMed ID: 11920888
[TBL] [Abstract][Full Text] [Related]
3. Free beta hCG screening of hydropic and non-hydropic Turner syndrome pregnancies.
Laundon CH; Spencer K; Macri JN; Anderson RW; Buchanan PD
Prenat Diagn; 1996 Sep; 16(9):853-6. PubMed ID: 8905900
[TBL] [Abstract][Full Text] [Related]
4. Second-trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops.
Lambert-Messerlian GM; Saller DN; Tumber MB; French CA; Peterson CJ; Canick JA
Prenat Diagn; 1998 Oct; 18(10):1061-7. PubMed ID: 9826898
[TBL] [Abstract][Full Text] [Related]
5. Multiple-marker screening in pregnancies with hydropic and nonhydropic Turner syndrome.
Saller DN; Canick JA; Schwartz S; Blitzer MG
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 1):1021-4. PubMed ID: 1384332
[TBL] [Abstract][Full Text] [Related]
6. The detection of non-immune hydrops through second-trimester maternal serum screening.
Saller DN; Canick JA; Oyer CE
Prenat Diagn; 1996 May; 16(5):431-5. PubMed ID: 8844001
[TBL] [Abstract][Full Text] [Related]
7. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
[TBL] [Abstract][Full Text] [Related]
8. Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy.
Ay E; Kavak ZN; Elter K; Gokaslan H; Pekin T
Aust N Z J Obstet Gynaecol; 2005 Aug; 45(4):283-8. PubMed ID: 16029293
[TBL] [Abstract][Full Text] [Related]
9. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
10. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
Rice JD; McIntosh SF; Halstead AC
Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658
[TBL] [Abstract][Full Text] [Related]
11. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study.
Phillips OP; Elias S; Shulman LP; Andersen RN; Morgan CD; Simpson JL
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701
[TBL] [Abstract][Full Text] [Related]
13. Maternal serum inhibin levels in second-trimester Down's syndrome pregnancies.
Cuckle HS; Holding S; Jones R
Prenat Diagn; 1994 May; 14(5):387-90. PubMed ID: 7521963
[TBL] [Abstract][Full Text] [Related]
14. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
15. Comparison and integration of first trimester fetal nuchal translucency and second trimester maternal serum screening for fetal Down syndrome.
Lam YH; Lee CP; Sin SY; Tang R; Wong HS; Wong SF; Fong DY; Tang MH; Woo HH
Prenat Diagn; 2002 Aug; 22(8):730-5. PubMed ID: 12210586
[TBL] [Abstract][Full Text] [Related]
16. Second trimester maternal serum ADAM12 levels in Down's syndrome pregnancies.
Donalson K; Turner S; Wastell H; Cuckle H
Prenat Diagn; 2008 Oct; 28(10):904-7. PubMed ID: 18785180
[TBL] [Abstract][Full Text] [Related]
17. SURUSS in perspective.
Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
[TBL] [Abstract][Full Text] [Related]
18. Second trimester serum markers.
Canick JA; MacRae AR
Semin Perinatol; 2005 Aug; 29(4):203-8. PubMed ID: 16104669
[TBL] [Abstract][Full Text] [Related]
19. Apparently low maternal serum inhibin A levels in second-trimester screening.
Lambert-Messerlian GM; Keren DF; Raphtis CS; Byberg K; Canick JA
Prenat Diagn; 2005 Oct; 25(10):967-8. PubMed ID: 16193465
[No Abstract] [Full Text] [Related]
20. Practical strategies in contingent sequential screening for Down syndrome.
Benn P; Wright D; Cuckle H
Prenat Diagn; 2005 Aug; 25(8):645-52. PubMed ID: 16049988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]